The Prime Minister Boris Johnson has lauded nearly £500m pounds of investment in the UK Life Sciences industry before a meeting with key biopharmaceutical industry leaders.
This monetary injection will be used to create at least 420 jobs and drive economic prosperity across the UK. It also brings the total investment in the industry to over £5bn since July.
The Prime Minister stated, “As we press ahead with our goal to become a science superpower, the new investments made today will help us forge life-changing breakthroughs against other diseases, such as cancer and dementia, while creating hundreds of high-skilled jobs across the country”.
The biggest individual investments came from GSK and Fujifilm Diosynth Biotechnologies, with the latter aiming to create the largest biopharmaceutical manufacturing site in the UK.
This exciting development follows The Department for International Trade’s decision to add a healthcare and life sciences landing page to the Investment Atlas. It is hoped this will further underline the attractiveness of the UK’s Life Sciences sector to potential inward investors as well as highlighting the extensive Government support available.
